Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4336)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 21, 2025 (publication date) through Mar 7, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Yin X, Deng N, Ding XY, Chen JL, Sun W. CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma. World J Gastroenterol 2025; 31(7): 101672 [PMID: 39991685 DOI: 10.3748/wjg.v31.i7.101672] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Yin X, Deng N, Ding XY, Chen JL, Sun W. CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma. World J Gastroenterol 2025; 31(7): 101672 [PMID: 39991685 DOI: 10.3748/wjg.v31.i7.101672] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i7/101672.htm |
| Number | Citing Articles |
| 1 |
Caifeng Gong, Jinglong Huang, Dandan Cao, Tianyi Liu, Qi Cai, Shuhui You, Yongkun Sun, Zhichao Jiang, Wei Wang, Lin Yang, Hong Zhao, Wen Zhang, Aiping Zhou. Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251407052
|
| 2 |
Shou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin, Hsin-Ju Tsai, Chia-Chang Chen, Chung-Hsin Chang, Teng-Yu Lee, Yen-Chun Peng. CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy. Cancers 2025; 17(18): 3058 doi: 10.3390/cancers17183058
|
| 3 |
Lilong Zhang, Yuefeng Zhang, Kunpeng Wang, Jiarui Feng, Chen Chen, Xinfei Liu, Weixing Wang. Prognostic impact of CRAFITY score in hepatocellular carcinoma patients treated with immune checkpoint inhibitors. iScience 2025; 28(12): 113976 doi: 10.1016/j.isci.2025.113976
|